期刊: INFLAMMATORY BOWEL DISEASES, 2022; 28 (7)
Background Patients with Crohn's disease (CD) experience intestinal inflammation. Ontamalimab (SHP647), a fully human immunoglobulin G(2) monoclonal a......
期刊: INFLAMMATORY BOWEL DISEASES, 2022; 28 (5)
Background Inflammatory bowel diseases (IBDs) are characterized by chronic inflammation and tissue damages in limited segments of the digestive tract.......
期刊: INFLAMMATORY BOWEL DISEASES, 2022; 28 (10)
Background The study sought to conduct a systematic review and meta-analysis of the risk of colorectal adenoma or cancer in patients with microscopic ......